Literature DB >> 2345481

Evaluation of the developmental effects on mice after prenatal, or pre- and postnatal exposure to 2,3-dimercaptopropane-1-sulfonic acid (DMPS).

J L Domingo1, A Ortega, M A Bosque, J Corbella.   

Abstract

The sodium salt of 2,3-dimercaptopropane-1-sulfonic acid (DMPS), a water soluble metal complexing agent, was administered to four groups of pregnant Swiss mice at 0, 70, 210, and 630 mg/kg/day by two dosing schedules: gestation day 14 until birth (prenatal exposure), and gestation day 14 until postnatal day 21 (pre- and postnatal section). Dams were allowed to deliver and the number of live and dead pups recorded. Each pup was sexed and weighed on days 0, 4, 14, and 21. Also, pinna detachment, incisor eruption and eye opening were monitored. No adverse effects on offspring survival or development were evident in either exposures at doses employed in this study. The "no observable effect level" (NOEL) for health hazard to the developing fetus or pup was 630 mg DMPS/kg/day. This dose is much higher than the amounts of DMPS usually administered in human heavy metal poisoning.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2345481     DOI: 10.1016/0024-3205(90)90361-t

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  2 in total

1.  Neutralizing Effects of Small Molecule Inhibitors and Metal Chelators on Coagulopathic Viperinae Snake Venom Toxins.

Authors:  Chunfang Xie; Laura-Oana Albulescu; Mátyás A Bittenbinder; Govert W Somsen; Freek J Vonk; Nicholas R Casewell; Jeroen Kool
Journal:  Biomedicines       Date:  2020-08-20

2.  Preclinical validation of a repurposed metal chelator as an early-intervention therapeutic for hemotoxic snakebite.

Authors:  Laura-Oana Albulescu; Melissa S Hale; Stuart Ainsworth; Jaffer Alsolaiss; Edouard Crittenden; Juan J Calvete; Chloe Evans; Mark C Wilkinson; Robert A Harrison; Jeroen Kool; Nicholas R Casewell
Journal:  Sci Transl Med       Date:  2020-05-06       Impact factor: 17.956

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.